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INTRODUCTION 
The control of pain is an important aspect of patient care for physicians who deal with 
cancer and has significant impact on the quality of life of patients 1. With appropriate 
care, pain can be controlled in 90% of patients who have advanced malignant 
conditions2• Despite the increased interest in pain as a symptom and advances in 
treatments, the general consensus has been that pain is still an under treated 
symptom of acute and chronic illness. Many barriers to adequate pain management 
have been identified, and one of the major barriers to achieving comfort for those in 
pain is inadequate knowledge on the part of health care professionals about pain and 
its treatment.1,3,4 
Recent studies have desaibed the prevalence and severity of pain due to cancer.5,6 
However very few studies have been published on the management of cancer pain in 
South Africa, although it has been documented that pain is often under treated.5 
Factors such as variations in practice, provider, setting and geographic location 
appear to influence cancer pain relief in South Africa. 40 
The aim of this study is to determine whether knowledge of pain and the attitudes of 
healthcare professionals towards pain is a barrier to effective pain management in 
oncology patients in South Africa. An assessment of hospital setting, and 
professional discipline may provide valuable inSight into pain management. 
It is hoped that with this research, knowledge deficits may be identified and an 
appropriate education program developed to target each healthcare professionals' 
needs, in order to improve pain management in oncology patients in South Africa. 
OBJECTIVES 
1. To evaluate knowledge and attitudes of nurses and physicians working 
with oncology patients at the Pretoria Academic Hospital and the Mary 
Potter Oncology Centre in Pretoria regarding the management of cancer 
pain. 
2. To determine whether differences exist between these groups based on 
practice setting, years of service or professional discipline. 
LITERATURE STUDY 
A. CANCER PAIN 
Adequate assessment is the critical first step to define a treatment strategy for 
the patient with pain. The Wor1d Health Organisation cancer Pain Relief 
Programme provides an approach for the management of cancer pain based 
upOn the construct that nothing would have a greater impact on the quality of 
life of patients with pain and cancer than the implementation of existing 
knowledge in pain assessment and treatment. Freedom from pain is seen as 
the right of every cancer patient, and access to pain therapy is a measure of 
respect for this right 
B. EPIDEMIOLOGY OF PAIN 
Prevalence data indicates that there are currently about 17 million people 
living with cancer wor1dwide7,8. The prevalence of pain increases with the 
progression of disease. The intensity, type and location of pain varies 
according to the primary site of cancer, extent of disease, progression and the 
treatments employed. Prevalence rates of 30 to 40 percent of patients in 
active therapy report pain and 70 to 90 percent of patients with advanced 
disease report pain. Uncontrolled pain precludes a satisfactory quality of life. 
Persistent pain markedly interferes with activities of daily living and social 
interactions. There is an increased risk of anxiety, depression and suicidal 
inclinations. Cancer pain is a major problem and Significantly impacts quality 
of life. 
C. BARRIERS TO PAIN ASSESSMENT AND ADEQUATE PAIN 
MANAGEMENT 
Patient related barriers 
• reluctance to report pain 
• reluctance to follow treatment recommendations 
• fear of tolerance 
• fear of addiction 
• concern about side effects 
• belief that pain is inevitable and must be accepted 
• fear of disease progression 
• fear of injections 
Physician related barriers 
• inadequate knowledge 
• poor assessment of pain 
• concem about regulation of controlled substances 
• fear of patient addiction 
• concem about side effects 
• concem about tolerance 
Institution related barriers 
• low priority given to cancer pain treatment 
• restrictive regulation of controlled substances 
• problems of availability of treatment or access to it 
• lack of economic resources 
• failure to use validated pain measurement tools 
D. ACUTE AND CHRONIC PAIN 
Pain caused by cancer may be caused by direct effects of the disease (e.g. 
tumour infiltration). or by treatment associated with the disease (e.g. 
chemotherapy and radiation therapyl A major distinction between acute and 
chronic pain may be found in the differences in central neural responses 
induced by the chronic afferent neural impulses of nociceptor activity. 
Changes in central neural processing induced by these impulses activate N-
methyl-D-aspartate (NMDA) receptors, which may allow a persistent pain 
sensation to occur in the presence of diminishing nociceptive activity. Acute 
pain may be associated with psychological reactions such as anxiety and fear 
and may be accompanied by activation of the sympathetic nervous system. 
Many of these reactions become habituated as pain persiSts. Adaptation of 
sympathetic activity and development of chronic vegetative signs e.g. 
decrease in appetite, malaise, irritability and sleep disturbances characterize 
chronic pain. The cancer patient suffers both acute and chronic pain. 




• sympathetically mediated pain 
E. TYPES OF PAIN 
Definition of pain: an unpleasant sensory and emotional experience 
associated with actual or potential tissue damage. Pain is always 
subjective. 
Somatic / nociceptive 
• Activation of nociceptors in cutaneous and deep muscular/skeletal 
tissues 
• Well localized (e.g. bone metastasis, post surgical incisional pain, 
myofascial pain, musculoskeletal pain, fracture, cellulitis) 
Visceral Pain 
• Infiltration, compression, distension of thoracic and abdominal viscera 
(e.g. liver metastasis, pancreatitis, peptiC ulcer, myocardial infarction) 
• Poorly localized, deep pain, pressure 
• Associated with nausea and vomiting 
• Often referred pain to cutaneous sites 
Neuropathic pain 
• Injury to peripheral or central nervous system 
• Deafferentation pain results after injury to peripheral neural structures 
• Central pain results after injury to central neural structures 
• In cancer patients, usually due to tumour compression or infiltration of 
nerve (e.g. radiation plexopathies, spinal cord compression, drug 
neuropathies ) 
• Severe pain often with buming or shock like sensations 
Complex regional pain syndrome 
• persistent focal pain with or without evidence of sympathetic 
involvement 
CANCER PAIN SYNDROMES 
Cancer pain has also been classified according to a series of common pain 
syndromes. 
Table 1: Acute Cancer Pain Syndromes8 
Acute P.iD Associated with Diagnosis •• d Therapeutic Interveatiou 
Acute pain associated with diagnostic interventions 
Lumbar puncture headache 
Arterial or venous blood sampling 
Bone-marrow biopsy 
Lumbar puncture 
Acute postoperative pain 
Acute pain caused by other therapeutic interventions 
Pleurodesis 
Tumour embolization 
Acute pain associated with analgesic techniques 
Injection pain 
Spinal opioid hyperalgesia syndrome 
Epidural injection pain 
Acute paiD Associated with ARtkaReer Therapies 
Acute pain associated with chemotherapy infusion techniques 




Antbracycline-associated flare reaction 
Acute pain associated with chemotherapy toxicity 
Mucositis 
Acute pain associated with hormonal therapy 
Hormone-induced acute pain flare in breast cancer 
Acute pain associated with radiation therapy 
Oropharyngeal mucositis 
Acute radiation enteritis and proctitis 
Acute pain associated with infection 
Acute herpetic neuralgia 
Table 2: Chronic Cancer Pain Syndromes8 
Tumour Related Paia Svadromes C.ronic Paia SVlldromes Associated 
Witla Cancer Tllerao! 
BonePai. Post cHmotllerapy pain syndromes 
Multifocal or generalized bone pain. Chronic painful peripheral neuropathy 
Vertebral syndromes Avascular necrosis of femoral or humeral 
Back pain and epidural compression head 
Pain syndromes of the bony pelvis and hip 
Head8eH and facial paba C~1Iic paba asIOCiated wi ... ormo_ 
Intracerebral tumor tHrapy 
Leptomeningeal metastases 
Gynecomastia with hormonal therapy for Base of skull metastases 
Painful cranial neuralgias prostate cancer 
Tumour involvemeat or"e periPHrai C.rollic posf5urgieal pain syndromes 
nervous system Postmastectomy pain syndrome 
Tumour-related radiculopathy Post-radical neck dissection pain 
Post-thoracotomy pain 
Brachial plexopathy Postoperative frozen shoulder 
Malignant lumbosacral plexopathy Phantom pain syndromes Stump pain 
Tumour-related mononeuropathy Postsurgical pelvic floor myalgia 
Paraneoplastic painful peripheral neuropathy 
PaiR syndromes or tH viscera ad C.rollic post radiation pain syndromes 
miscellaneous tumour-related syndromes Plexopathies 
Hepatic distension syndrome Chronic radiation myelopathy 
Midline retroperitoneal syndrome Chronic radiation enteritis and proctitis 
Chronic intestinal obstruction Burning perineum syndrome 
Peritoneal carcinomatosis Osteoradionecrosis 
Malignant perineal pain 
Ureteric obstruction 
F. PAIN ASSESSMENT 
Medical History (Including alcohol or drug dependence)1o 
Oncological history, i.e. extent of di._ and prognosis 
Pain history (Believe U'le patients' complaint of pain) 
• quality 
• intensity using a numerical rating scale, visual analogue 
scale or verbal descriptor scale 
• Location and radiation 
• Palliating and provoking factors 
• Temporal characteristics: acute, subacute, chronic 
• Duration 
• Cause 
• Impact on activities, sleep and mood 
• Associated factors such as numbness, weakness, vasomotor 
changes and fatigue 
• Previous medication (drug, dose frequency, effect, side 
effects and duration) 
Look out for common pain syndromes: Acute and chronic 
Psychosocial evaluation 
• Psychological symptoms e.g. anxiety, depression, anger 
• PsychiatriC disorder, e.g. delirium, major depression 
• "Meaning- of pain to significant others 
• change in mood state 
• family functioning 
• financial problems 
• psychosocial support system 
• patient's expectations and preconceptions regarding pain 
management 
• cultural and language issues 
• spiritual issues, guilt and regret 
Physical examination 
• General medical 
• Neurological 
• Pain site and surrounding area 
• Possibility of referred pain 





• CT scans I MRI 
• Blood tests as indicated 
Impressions 
Treatment plan 
• Possible aetiology 
• Probable pathophysiology 
• aim is to relieve and prevent pain 
• good communication 
• reassurance of patient and family 
• encourage patient participation 
• multidisciplinary plan of care to address disease, physical, 
psychosocial problems, social difficulties, cultural issues and 
spiritual concerns 
• repeated reassessment 
Modalities of treatment 
• treat underlying cancer 
• analgesics - opiates and nOn-opiates 
• adjuvants - tricyclic antidepressants, anti conwlsants, local 
anaesthetics, steroids 
• manage drug side effects 
• TENS 
neurolytic procedures 
• Physical interventions - maintain mobility, heat, cold, 
immobilization, repositioning, massage, vibration, exercise, 
acupuncture 
• Psychological interventions - relaxation and imagery; 
hypnosis; cognitive distraction; patient education; 
psychotherapy; support groups; pastoral counselling 
• Lifestyle modification 
• Treat any aspect causing suffering 
Discharge planning 
The patient needs to be assessed regularly and must have a contact person 
should any new problem arise. 
G. TREATMENT OF CANCER PAIN 
Treatment with analgeSic drugs is the mainstay of cancer pain management. Drugs 
whose primary clinical action is the relief of pain are conventionally classified on the 
basis of the site of activity at opioid receptors as either opioid or non-opioid 
analgesics. A third class, the adjuvant analgesics, are drugs with other primary 
indications that can be effective analgesics in specific circumstances. The major 
group of drugs used in cancer pain management are the opioid analgesics.8.11.12.13.14 
1. OPIOIDS 
Opioid receptors 
J1 (J11 + J12) 
(J 
Response on activation 
• analgesia 
• respiratory depression 
• miosis 
• euphoria 










not a true opioid receptor because effects not 
reversed by Naloxone 
Opioid analgesics 















Partial agonists (ceiling effect) 
• buprenorphine 
Agonist - antagonists (agonist at one receptor and antagonist at another - ceiling 
effect to analgesia) 
• pentazocine ~ agonist on 1C 






Can cause withdrawal syndrome 
Table 3: Equinalgesic doses15,18 
Equianalgesic Doses· 
(mg) 
OpioidsIN arcotics Parenteral Oral Conversion Factor Comments 
IMISQIIV IMISQIIV to PO 
Opioid Agonists: 10 30 3 Standard of comparison. Also available as controJled release tablets and rectal 
Morphine-like, mu agonists) suppositories. Single oral dose may require conversion of 6. 
Morphine 
Codeine 130 200NR 1.5 Doses over 65mg may produce diminishing incremental analgesia. Oral tablets 
usually compounded with non-opioid. 
Dihydrocodeine (DFl18) - 150?NR - Equianalgesic data not available. Usually compounded with non-opioid 
Fentanyl (Duragesic) - - - Transdermal (Duragesic) patches available in 25,50,75, 100 J.lgIhr. 
Equianalgesic conversion is controversial. Using oralIparenteraJ ratio 3/1 for 
morphine, 1 J.l.g/hr oftransdermaJ fentanyl roughly equivalent to oral morphine 
2mg/2 hr. Toxic metabolite norfentanyl may accumulate. 
Methadone (physeptone) 10 20 2 Accumulates on day 2-5 
Meperidine (pethidine) 75 300NR 2 Normeperidine (toxic metabolite) accumulates with repetitive doses, causing 
CNS excitation. Avoid high frequent doses, chronic use and use in patients 
with impaired renal function. 
Propoxyphene hydrochloride - 400?NR - 6S-13Omg PO approximately equal to 116 the doses listed in this chart. 
Propoxyphene napsylate Propoxyphene and toxic metabolite norpropoxyphene accumulate with 
repetitive dosing 
Partial Agonists: 0.4 - - May produce withdrawal in opioid-dependent patients. May be given with mu 
Buprenorphine agonists. 
(Temgesic) 
Mixed Agonist-antagonists: Limited usefulness in cancer pain. Do NOT use in combination with morphine-like drugs: may reverse analgesia; may precipitate 
withdrawal in opioid-dependent patients 
Nalbuphine (Nubain) 10 -
Pentazocine (Sasenol) 
60 180 3 
• Equianalgesic doses are approximate; use only as a guideline. All doses must be titrated to individual's response. Parenteral doses 
are initial 1M doses for acute pain in adults; may be used to convert doses for IV infusions and repeated small IV boluses. For single 
IV bolus, use half 1M dose. For patients over 70, consider lowering starting parenteral doses by 25-30%. The oral doses are not 
necessarily starting doses. 
• NR - not recommended at that dose. 
• ? - Dose is questionable due to lack of well controlled research. 
15 
World Health Organization Analgesic Ladder17,18 
Intensity of pain is the prime consideration in analgesic selection. The WHO 
analgesic ladder advocates three basic steps: 
1. Mild cancer related pain should be treated with a non-opioid analgesic, 
which should be combined with adjuvant drugs if a specific indication for 
these exists. 
2. Moderate pain or failure to respond to non-opioid analgesics should be 
treated with a "weak· opioid e.g. codeine, hydrocodone, dihydrocodeine, 
or propoxyphene. These drugs are often combined with non-opioids and 
may be co-administered with an adjuvant analgesic. 
3. Severe pain not responding on the second step of the analgesic ladder 
should receive a "strong" opioid e.g. morphine, diamorphine, fentanyl, 
oxycodone, hydromorphone, methadone. These drugs may also be 
combined with a non-opioid analgesic or an adjuvant drug. 
When combined with appropriate dosing guidelines, this approach is capable of 
providing adequate relief to roughly 80% of patients. 
Scheduling opioid administration 
1. II Around the clock dosing- - to provide the patient with continuous relief by 
pre-empting recurring pain 
2. Rescue doses is a supplemental dose given on an as-needed basis to 
treat pain that breaks through the regular sd1edule 
Dose selection and adjustment 
Initial dose selection: 10 - 20mg oral morphine every 4 hours. Dose titration: 
gradually escalate dose until adequate analgesia or intolerable side effects. Increase 
dose in increments of 30 - 50%. The absolute dose is immaterial as long as the 
balance between analgesia and side effects remain favourable. E.g. use oral 
morphine q 4 hours and the same dose for breakthrough pain given as often as 
required and then review total dose of morphine daily. 
Adverse effects of opioid analgesics 
1. sedation 
2. constipation 
3. nausea and vomiting 
4. urinary retention 
5. multifocal myoclonus 
6. respiratory depression 
7. urticaria and pruritis 
2. NON OPIOIO ANALGESICS 
Non opioid analgesics encompass the non-steroidal anti-inflammatory drugs 
(NSAIO's), paracetamol and nefopam - they are used widely in the management of 
mild and moderate pain. 
Classification of NSAIO's 
Salicylates • aspirin 
• diflunisal 











Fenamates • flufenamic acid 
• mefenamic acid 
Oxicams • piroxicam 
• tenoxicans 
Pyrazolones • azapropazone 
Phenylbutazone 
Butazones • nabumetone 
Table 4 : Selected nonopioid analgesics: analgesic dosage and comparative efficacy to standards19 
Drug Proprietary Average Dose Maximal Pediatric Analgesic Efficacy Plasma Comments 
Names analgesic interval daily Dose compared to standards half-
(not all- dose (mg)· (hours) dose (mgIkg) life 
inclusive) (mg) (hours) 
Acetaminophen numerous 500- 4-6 4,000 10-15 Comparable to aspirin 2-3 
1,000 q4-6hr 
Salicylates Numerous 50-1,000 4-6 4,000 10-15 0.25 
Aspirin q4-6hr 
Diflunisal Dolobid 1,000 8-12 1,500 - 500mg superior to 8-12 -
initial, 500 aspirin, 650mg with 
subsequent slower onset and longer 
duration; an initial dose 
of 1,00Omg significantly 
shortens time to onset 
~AID'I Brufen 200-400 4-6 2,400 IOq6- Superior at 200mg to 2-2.5 -
Propionic 8hr aspirin 650mg 
Acids 
Ibuprofen 




Naproxen ALeve 220mg 8-12 - - Comparable to aspirin 2-3 -
sodiumOTC 
Fenoprofen - 200 4-6 800 -
Ketoprofen 25-50 6-8 300 -
Indolacetlc Indocid 25 8-12 100 - Comparable to aspirin 2 Not routinely used 
Acids 650mg because of high 
Indomethacin incidence of side 
effects; rectal, N, 
and sustained-release 
oral forms available 
for adults 
Pyrrolacetic Toradol 30or6Omg 6 150 first - In the range of 6-l2mg 6 Limit treatment to 5 
Acids IMor day, 120 ofmorpbine days; may 
Ketorolac 30mgN thereafter precipitate renal 
initial, 15 failure in dehydrated 
or 30mg IV patients 
orIM 
subsequent 
Anthranilic Ponstan 500 initial, 6 1,500 - Comparable to aspirin 2 




Phenylaeetic: Catafiam sOmg 8 ISO - Superior in efficacy and -
Adds analgesic duration to 
Diclofenac aspirin 6SOmg 
potassium 
* All doses are oral unless otherwise specified 
21 
Adverse Effects of NSAID's 
1. Gastrointestinal: dyspepsia, nausea, vomiting, peptic ulcer disease 
2. Nephrotoxicity : fluid retention, impaired renal function 
3. Bronchospasm in asthmatics 
4. Inhibition of platelet aggregation 







3. ADJUVANT ANALGESICS IN PAIN MANAGEMENT 
The term "adjuvant analgesic· describes any drug that has a primary indication other 
than pain, but is analgesic in some painful conditions. 
Antidepressants and anticonvulsants may be effective in neuropathic pain.11 
Psychostimulants can deaease opioid-induced sedation. Glucocorticoids are 
effective anti-inflammatory agents and are also used to reduce pain associated with 
brain oedema and epidural metastases. Muscle relaxants, anxiolytics, 
antispasmodics and neuroteptics are also employed for specific indications. 
Bisphosphonates are indicated for bone metastases. Caution must be exercised in 
the use of adjuvant drugs with sedative properties, because the dose of opioids 
should not be compromised by the toxicities of these secondary agents. 
Table 5: Commonly Used Adjuvant Analgesics for Cancer Pain8 
Drug Category Indications Drugs Common Comments 
Toxicities 
Antidepressants Neuropathic Amitriptyline Sedation, dry Begin with low 
pain Nortriptyline mouth, doses (10-25mg); 
Desipramine constipation, increase dose 
postural every few days; 
hypotension, expect to see pain 
urinary relief within several 
retention days, mood 
elevation within 
several weeks 
Anticonwlsants Neuropathic Phenytoin Drowsiness, Use loading dose 
pain, Carbamazepine dizziness, with phenytoin; 
myodonic Valproic acid nausea, rash, monitor platelets 
jerks Clonazepam bone marrow with 
Gabapentin depression carbamazepine 
Psychostimulants Opioid- Dextroamphetamine Nervousness, Give ear1y in the 
induced Methylphenidate initabilHy, day to avoid 
sedation insomnia, insomnia; do not 
dizziness, dry use if patient is 
mouth already delirious or 
confused 
Corticosteroids Spinal cord Decadron Gastritis, 
compression, Methylprednisolone insomnia, fluid, 







Muscle relaxants Muscle Diazepam Sedation, 




Benzodiazepines Muscle Diazepam Sedation, No analgesics, 
spasm, Lorazepam delirium, synergistic effect 
anxiety, Alprazolam hypotension, with opioids can 
insomnia Temazepam headache, cause respiratory 
respiratory depression 
depression 
Antispasmodics GI or bladder Diphenoxylate & Sedation, dry 
spasm atropine, mouth, 
loperamide, constipation 
scopolamine patch 
Neuroleptics Delirium, Haloperidol, Sedation, Useful for 
agitation, prochlorperazine, orthostatic symptoms other 
nausea and chlorpromazine hypotension, than pain; 
vomiting, confusion, (methotrimeprazine 
hiccoughs extrapyramidal has analgesic 
reactions properties) 
Bisphosphonates Bone pain Pamidronate Hypocalcemia, Delays time to 
fever, GI painful skeletal 
disturbances, events; also used 
anemia with analgesics for 
bone pain 
4. OTHER MODALITIES IN PAIN MANAGEMENT 
• Transcutaneous electrical nerve stimulation (TENS) 
• Neurolytic procedures 






• psychological interventions - relaxation and imagery 
- hypnosis 




The vast majority of cancer pain can be well controlled with therapies readily 
available to most physicians. Providing this optimal cancer pain relief tests the 
skills and commitment of physicians, nurses and pharmacists. 
H. KNOWLEDGE AND ATTITUDES TOWARDS PAIN MANAGEMENT 
Studies of healthcare professionals knowledge and attitudes around the wor1d have 
documented numerous misconceptions about cancer pain' management.26 These 
include misunderstandings about the prevalence and inevitability of cancer pain; 
misconceptions about pain assessment; inappropriate beliefs about addiction and 
drug tolerance; inappropriate knowledge of opioid pharmacology including choice of 
drug, doses, routes and schedules of administration. Most of these s,udies focused 
on single groUps1.3.15,20.22.25of healthcare professionals, however a few studies 
compared responses of different healthcare professionals4•26 to the same set of 
questions. 
From these comparative studies it was found that physicians were most 
knowledgeable about pain management and pharmacists were least knowledgeable, 
with nurses knowledge in between these two groups. Studies of nurses, reported that 
hospice nurses scored higher than hospital oncology nurses regarding overall pain 
management. 27 
Amongst physicians it was reported that medical oncologists were more aggressive 
in the management of pain than radiation oncologists3 and healthcare professionals 
in anaesthesiology had the most knowledge regarding pain management, while those 
in surgical disciplines the least. Studies reported poor pain management knowledge 
in primary care physicians when compared to medical oncologists. 28,29 
Studies of knowledge and attitudes to pain management have been done in 
numerous countries including Italy,30 Belgium,31 France,35 USA,27,28,32.33 Australia,34 
Taiwan,36 and Israel.37 These studies show pain knowledge deficits in healthcare 
professionals although different measurement tools in different languages were used. 
No similar studies have been done to date in South Africa. 
Beck found however that in South Africa, the lowest incidence of severe pain was 
experienced in the hospice setting while the highest incidence was in inpatients. 
Beck also found that in the African culture, views about cancer, prevent patients from 
seeking treatment, even for pain.39 The main barrier to effective pain management 
according to the research by Beck was the lack of knowledge by professionals and 
patients, although a lack of resources and cultural differences were also found to be 
significant barriers.40 
From these studies it appears that no standardised method exists for measuring 
knowledge and attitudes towards cancer pain management, many surveys were 
developed for particular studies and some surveys were modified from other stLidies. 
The Nurse's Knowledge and Attitude Survey was however used in numerous studies 
and has been statistically validated to discriminate between levels of 
expertise.21 ,22,23,38 
METHOD 
A questionnaire20 to assess prevailing knowledge and beliefs by heaHhcare 
professionals towards the management of pain was used. The Nurses Knowledge 
and Attitudes Survey (NKAS) was developed in 1987 and has been used 
extensively.21 22 23 38 This survey was developed at the University of Wisconsin and 
consists of 37 items (Appendix II). 
Regarding issues of reliability and validity: This tool has been developed over several 
years. Content validity has been established by a review of pain experts. The 
content of the tool is derived from current standards of pain management such as the 
American Pain Society, the WHO and the Agency for HeaHh Care POlicy and 
Research. Construct validity has been established by comparing scores of nurses at 
various levels of expertise such as students, new graduates, oncology nurses, 
graduate students and senior pain experts. The tool was identified as discriminating 
between levels of expertise. Test-retest reliability was established (r>.50) by repeat 
testing in a continuing education class. Internal consistency reliability was 
established (alpha r> .70) with items reflecting both knowledge and attitude domains. 
The survey was distributed to a convenience sample of nurses and physicians 
working with oncology patients at Pretoria Academic Hospital, a state hospital and 
Mary Potter Oncology Centre, a private hospital with attached hospice. Convenience 
sampling was used as I thought that the staff working at these institutions would be 
fairly representative of professionals treating people with cancer pain, it would be a 
on a voluntary participation basis, all the institutions listed were in close proximity to 
where I live and work and accessing the staff via questionnaires would not present a 
problem. I would also be able to follow-up quite easily on any queries which may 
have arisen. Because some members of this population of professionals have no 
chance of being sampled, the extent to which this sample represents the entire 
population in this group cannot be known. However, it does provide some insights 
and could be a good source of data in exploratory research of the nature that I am 
doing. Each survey included a statement (Appendix I) indicating the purpose of the 
research and that all data is strictly confidential. All resuHs are presented in 
summary form and no individuals are identified. Surveys were distributed and 
statistics for each response is reported. As surveys were distributed to heaHhcare 
professionals, in order to protect their anonymity a signed informed consent was 
excluded. No patients were evaluated for this study and participation was completely 
voluntary. The return of the completed survey implied the consent of the subject 
Statistics were done using the NCSS statistics program. 
The Ethics Committee of the Pretoria Academic Hospital and University of Cape 
Town approved this study. 
RESULTS 
Of 180 surveys distributed. 103 were returned. giving a response rate of 57.2%. 
Average physician response is reported to be 54% with 68% for non physicians.43 No 
system was in place to encourage the completion and return of the surveys 01' to 
ensure complete comprehension of the questions. Interpretation and language issues 
may have played a role in the poor response rate, although this was not evaluated. 
Also no incentive was provided to encourage a better return of the surveys. A total of 
103 healthcare professionals responded to the survey. One healthcare professional 
did not agree to complete the survey and two of the surveys were inadequately 
completed and thus excluded from the study. Reasons for non completion was not 
obtained. 
Most of the participants were nurses (76%) with the least being pharmacists (4%), 
and physicians comprised the rest (20%). This appears to be a fair representation of 
the population studied. however as this was a small sample it may make comparison 
diffICUlt. Unfortunately the number of available pharmacists at these institutions was 
very limited and they should perhaps not have been included in the research study. 
Only four pharmacists completed the survey and as this may not be an accurate 
representation of knowledge and attitudes of pharmacists, these surveys have also 
been excluded. The study was thus only able to compare physicians and nurses 
knowledge and attitudes towards cancer pain management. Demographic data of the 
responding healthcare professionals is summarised in table 1. 
The highest qualification was a diploma in 58% of participants, which may represent 
the large proportion of the nurses. A bachelors degree was held by 34% of the 
participants. The majority of participants worked in the state hospital setting (72°.4) 
with only a minority of participants working in a hospice setting (7%). Unfortunately 
the survey did not make allowance for healthcare professionals working perhaps in 
two different settings, this was an oversight. As the survey was designed to assess 
cancer pain management the majority of participants worked in an oncology area 
(67%). Only 11 male participants completed the survey while 89 were female, this 
may represent the gender distribution often seen in the medical field, as most nursing 
staff is female. Most partiCipants were between the ages of 30 and 50 (47%). with the 
average years of experience being 14.12 years. 98% of participants did see cancer 
patients. 
Table 2 lists the 37 survey questions and the percentage of correct answers for this 
group of nurses and physicians. The chi-square test was used to detennine the p 
value, where p < 0.05 is considered a statistically significant difference between the 
two groups. 












State hospital .72 
Hospice 7 









Averaqeage 38,06 (23-56 years) 
20-30 years 13 
30-40 years 24 
40-50 years 23 
5().6() years 15 
Averaae ~rs exoerience 14.12 (1-34 years) 
Cancer visits 
Never see cancer patients 1 
Seldom see cancer patients 20 
Often see cancer patients 78 
The phySICIans scored better II"Ilhe overall score for the 37 Quesnof'ls as compared to 
the nurses Lebovlts' reported a similar outcome whereas the Mudy by Furstenbefg 
found nlJl'ses to be most knowledgeable " Companson however could be inaccurate 
due to the dltlerent measuremen1l1"1struments used 11"1 these studies Also South 
Afnca has eleven offiCiallall9uages Wlth no single one common to all " , there may 
have been dtfflcu~y wuh the wording and language of the survey as ~ was only 
adrrumstered In English The SUNDy did not assess partlClpan1 comprehenSion 
therefore questIOn bias can not be exc!llOe<I The physicians scored poorly In 
QfJestlOflS relaung to non-drug inteIVenUOM (Question 1) and the pharmacokmeliCS of 
opoOIds (Question II). This has also been reponed In other studies. however not 
bmlled 10 physICians ' 1'1 v PhySICians and nurses obIa.necl poor 5(;01'" on the 
QueSUOtlS relaled to pain assessment (QuestlOfl 36). both groups a!so fe~ that 
patients over report pain (Question 34) This IS COMistent 'Mlh most ()(her 
studies' l. ' ""'" The nurses scored poorly m Questions related to equlanalgeSic doses 
01 opoolds (QuestlOll 9) sKle effects fA QPioIOs (QuestIOn 28) ana norrdrug 
interventions (QuestIOn 7 & 22) Similar results have al$O been reported 10 other 
studies , . ,~;>\ )I Poor fesUnS for these issues has also Deen reported for phySICoans 
Table 3 shows the summary of the average correct SCQff!S relatIVe to hoghesl 
Qualification, practice setting. chOical area of practfce. years of expenence and age 
Results were analysed for each of the five variables by analyS4s of vanance (ANOVA) 
bot because of the lack of equal distribution among the cate,.ones of each vanable, 
complete and detailed compansons were imposSible 
11 was not possible to come to a eonc!usi()(1 regard ing hi{jhest Qualification. or 
prac1Ise settong OUl!! to the unequal Ol$lf1butlon USing ANOVA. therefore the two 
sample t-test was U!led to determIne a po5S4b1e oltlerente between two more evenly 
dlStnbuted vanables 11 appears from the study that healthtare professionals With 
higher qual!licatioOs have bette!' ltnoYdeoge and aWIllde'S towards cancer pain 
managemens (p'" 0 0000(6) FlQure 1 
_0.0 ..... , 
-
Heallhcare protesslOnals pracllslflg In a prIVate sening (p" 0.005) and In the ctinlcal 
area of medicine (p '" 0 015) also appear to have better scores than those In the state 
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Heallhcare professiOllals Wllh less than Meen years of e ~pel1ence seemed to 
achieve beller scores than those wah more than fifteen years of expenence. (p" 
0025) ThiS may be an Indlcatoon of better educatIOn regarding paIn management rn 
recent years Scores dKlnot however drffer by age group One woutd have expected 
that the scores would mdeed differ by age group, In thaI older partiCipants would fare 
worse being the group With presumably the most years e~perience Ftgure 3 
The findings of this study should be interpreted cau\lously due to the poSSible 
sampling bias as well as limrtations of the SUNey measure The small sample size 
and uneven distribution of hllalthcare profesSionals made It diffICult 10 detect 
differences ,n the different parameters 

P .; 0.05 Slallsl,cally sIgOlficant 
35 
Table 3 Summary of average scores for qualification, prac:lice setting, clinical area, years of .~perience and age 
I::!!!ilr.est QUi!I,lIcauon """ ~[iI!:!g ~1I1!!1I """ C~mcal&:H .... Yurs of "'" ... "'" Uoerlftnsa: 
"'~t '" S01e "'CI~~1a1 " ""'"" 2tl < 15 years " 20 - 30 years " 
~- " """" " Oncology " > 15yur$ 22 30 - 40 YUr5 " Baclle lO(s degrefl " Pnval9 Prilchoe " "",,, " 40 - 50 yllilfs " "". 20 ""'. 20 5O -60y~ " 
P.OOOOOO6 p " 0 00!0 P_ OO\5 P~OO25 P-056 
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DISCUSSION 
The current study examined the knowledge of and attitudes toward cancer pain 
management of a sample of physicians and nurses caring for cancer patients at the 
Pretoria Academic Hospital and Mary Potter Oncology Centre. 
This was a convenience sample of nurses and physicians working with cancer 
patients. An anonymous survey was distributed and participation in the study was 
voluntary, with completion and submission of the survey taken as implying consent. 
The survey was only available in English, thus language or comprehension issues 
may have affected the outcome, as South Africa has many diverse cultures with 
many different languages. The response rate to this survey was 57.2%, which 
appears to be an average response rate for healthcare professionals, although 
impacts the value of the study due to non-response bias. No attempt was made to 
encourage retum of the surveys and the non-participants were not evaluated in any 
way. 
The overall correct score of 66% reflects some knowledge deficiencies regarding 
currently accepted principles of cancer pain management practice, as well as beliefs 
that could interfere with optimal care. This appears to be consistent with other 
studies. 
Some healthcare profeSSionals appeared confused about appropriate methods for 
assessing pain, particular1y about the value of patient reports of pain intensity. Of 
concem is that most respondents appeared to suspect that a high percentage of 
patients over report pain, although one of the most basic principles of pain 
assessment is realising that pain is subjective and accepting the patients report of 
pain. It seemed that some lacked adequate knowledge of the fundamental facts of 
opioid pharmacology, including choice of drug, routes of administration and dosing 
schedule. Issues relating to drug tolerance, side effects and addiction in particular 
appeared not to be well understood. The role of non-drug interventions for the 
management of cancer pain also seems unclear. These results appear to be 
consistent with reports from other countries. 
Conflicting results have been reported in the literature on whether physicians or 
nurses have greater knowledge regarding cancer pain management, however many 
different tools have been used to evaluate knowledge and this does not allow for 
direct comparison. In this sample of healthcare professionals it appeared that the 
physicians scored better overall compared to the nurses scores. Any difference 
would perhaps imply different education programs, with emphasis on different 
aspects of pain management, however this was not evaluated. Healthcare 
profeSsionals with higher qualifications appeared to have better scores than those 
with lower qualifications. Private practice and healthcare profeSSionals in the clinical 
area of medicine also appeared to have improved scores. It is possible that the 
private sector has more access to education programs and different resources, 
thereby having a better score. Age of the professionals did not seem to have an 
impact on the scores, however the more years of experience the poorer the score. 
This may be due to improved education in pain management in recent years. 
The findings of this study should be interpreted cautiously due to the possible 
sampling bias as well as limitations of the survey measure. The small sample size 
and uneven distribution of healthcare professionals made it difficult to detect 
differences in the different parameters. 
The results of this study, however appear to be generally consistent with results from 
other studies of physicians and nurses in terms of knowledge of and attitudes 
towards cancer pain management. 4.26.27 
The study indicates a continuing need for education programs in the area of cancer 
pain management. Educational programs should focus on convincing all healthcare 
professionals involved in caring for patients with cancer that treatment of cancer pain 
is an important healthcare goal that requires their personal commitment and 
involvement. 
CONCLUSIONS 
The results of this survey reflect some knowledge deficiencies regarding currently 
accepted principles of cancer pain management, as well as beliefs that could 
interfere with optimal care. Few studies have been published regarding cancer pain 
management in South Africa, and this small study may indicate the need for more 
thorough investigation into knowledge deficits and attitudes toward cancer pain 
management. The study also reflects a continuing need for education programs in 
the area of cancer pain management. 
RECOMMENDATIONS 
Further research is needed in the management of cancer pain in South Africa. The 
impact of cultural differences on the perception and management of pain needs to be 
explored more fully, both amongst the heatthcare professionals and their patients. 
Erucation programs should be initiated in all healthcare professionals training. 
Emphasis should be placed on the correct assessment and management of pain. 
The greatest deficiencies found in this study, appeared to be in the appropriate 
assessment of pain and fundamental concepts of opioid pharmacology, including 
choice of drug, routes of administration and dosing schedule. The role of non-drug 
interventions needs to be emphasised particularly in resource poor countries such as 
South Africa. Continued medical education should be encouraged with regular 
attention to pain management 
The effect of these education programs should be regularly assessed by the training 
institutions, to ensure correct and appropriate attitudes and knowledge towards the 
management of cancer pain. 
APPENDIX I 
MANAGEMENT OF CANCER PAIN: KNOWLEDGE AND ATTITUDES OF 
HEAL THCARE PROFESSIONALS. 
The attached survey has been distributed to healthcare professionals who see or 
treat cancer patients. The aim of this survey is to assess knowledge and attitudes of 
healthcare professionals towards the management of cancer pain. 
All information will be presented in summary form and no individual will be identified. 
Completion of this survey is voluntary and will take about ten minutes. 
Thank you for your cooperation. 
D Yes, I agree to complete this survey 
D No, I do not agree to complete this survey 
By filling in this questionnaire I consent voluntarily to complete this survey and 
understand that the survey is intended for research purposes. 
APPENDIXD 
SU"ey - Optional- Anonym.ous 
• General Information about Yoa 














N . - ursmg 
_Pharmacy 
_Medicine 
_Other Specify ___ _ 
Specify ___ _ Specify ___ _ Specify ___ _ 
Years experience as health professional: __ _ Age: ___ Gender: __ _ 
Do VOIl see cancer patie"ts 
Never --- Seldom --- ___ Often 
True I False - Circle the correct answer 
T F 1. Observable changes in vital signs must be relied upon to verify a patient's 
statement that he has severe pain 
T F 2. Because of an underdeveloped neurological system, children under 2 
years of age have decreased pain sensitivity and limited memory of painful 
experiences 
T F 3. If the patient can be distracted from his pain this usually means that he 
does NOT have high pain intensity 
T F 4. Patients may sleep in spite of severe pain 
T F 5. Comparable stimuli in different people produce the same intensity of pain 
T F 6. Aspirin and other non steroidal anti-inflammatory agents are NOT 
effective analgesics for bone pain caused by metastases 
T F 7. Non-drug interventions (e.g. hea~ music, imagery, etc.) are very effective 
for mild-moderate pain control but are rarely helpful for more severe pain 
T F 8. Respiratory depression rarely occurs in patients who have been receiving 
opioids over a period of months 
T F 9. Aspirin 650mg PO is approximately equal in analgesic effect to 
meperidine (pethidine 50mg PO) 
T F 10. The World Health Organization pain ladder suggests using single 
analgesic agents rather than combining classes of drugs (e.g. combining an 
opioid with a non-steroidal agent) 
T F 11. The usual duration of action of meperidine (pethidine) 1M is 4-5 hours 
T F 12. Research shows that prometbazjme (phenergan) is a reliable potentiator 
of opioid analgesics 
T F 13. Patients with a history of substance abuse should not be given opioids 
for pain because they are at a high risk for repeated addiction 
T F 14. Beyond a certain dosage of morphine increases in dosage will NOT 
increase pain relief 
T F 15. Elderly patients cannot tolerate opioids for pain relief 
T F 16. The patient with pain should be encouraged to endure as much pain as 
possible before resorting to a pain relief measure 
T F 17. Children less than 11 years cannot report pain with reliability and 
therefore, the nurse should rely on the parents' assessment of the child's 
pain intensity 
T F 18. Based on one's religious beliefs a patient may think that pain and 
suffering is necessary 
T F 19. After the initial recommended dose of opioid analgesic, subsequent 
doses are adjusted in accordance with the individual patient's response 
T F 20. The patient should be advised to use non--drug techniques alone rather 
that concurrently with pain medication 
T F 21. Giving patients sterile water by injection (Placebo) is often a useful test 
to determine if the pain is real 
T F 22. In order to be effective, heat and cold should only be applied to the 
painful area 
Multiple Choice - Circle the correct answer 
23. The recommended route of administration of opioid analgesics to patients with 






f. I don't know 
24. The recommended route of administration of opioid analgesics to patients with 






f. I don't know 
25. Which of the following analgesic medications is considered the drug of choice for 
the treatment of prolonged moderate to severe pain for cancer patients 
a. Brompton's cocktail 
b. Codeine 
c. Morphine 
d. Meperidine (pethidine) 
e. Methadone 
f. I don't know 
26. Which of the following IV doses of morphine administered over a 4 hour period 
would be equivalent to 30mg of oral morphine given q4 hours 
a. Morphine 5mg IV 
b. Morphine IOmg IV 
c. Morphine 30mg 1M 
d. Morphine 60mg IV 
27. Analgesics for post-operative pain should initially be given 
a. Around the clock on a fixed schedule 
b. Only when the patient asks for the medication 
c. Only when the nurse determines that the patient has moderate or greater 
discomfort 
28. A patient with chronic cancer pain has been receiving daily opioid analgesics for 2 
months. The dose increased during this period. Yesterday the patient was receiving 
morphine 200mg/hour intravenously. Today he has been receiving 25Omg/hr 
intravenously for 3 hours. The likelihood of the patient developing clinically 
significant respiratory depression is 





29. Analgesia for chronic cancer pain should be given 
a. Around the clock on a fixed schedule 
b. Only when the patient asks for the medication 
c. Only when the nurse determines that the patient has moderate or greater 
discomfort 
30. The most likely explanation for why a patient with pain would request increased 
doses of pain medication is 
a. The patient is experiencing increased pain 
b. The patient is experiencing increased anxiety or depression 
c. The patient is requesting more staff attention 
d. The patient's requests are related to addiction 
31. Which of the following drugs are useful for the treatment of cancer pain? 
a. Ibuprofen (Brufen) 
b. Methadane (physeptone) 
c. Amitriptyline (Tryptanol) 
d. All of the above 
32. The most accurate judge of the intensity of the patient's pain is 
a. the treating physician 
b. the patient's primary nurse 
c. the patient 
d the phannacist 
e. the patient's spouse or family 
33. Which of the following describes the best approach for cultural considerations in 
caring for patients in pain: 
a Because of the diverse and mixed cultures there are no longer cultural 
influences on the pain experience 
b. Nurses should use knowledge that has defined clearly the influence of pain on 
culture (e.g. Asian patients are generally stoic, Italians are expressive and 
exaggerate their pain, etc.) 
c. Patients should be individually assessed to determine cultural influences on 
pain 
34. What do you think is the percent of patients who over report the amount of pain 
they have? Circle the correct answer 
o 10 20 30 40 50 60 70 80 90 100% 
35. Narcoticlopioid addiction is defined as psychological dependence accompanied by 
overwhelming concern with obtaining and using narcotics for psychic effect, not for 
medical reasons. It may occur with or without the physiological changes of tolerance 
to analgesia and physical dependence (withdrawal). 
Using this definition, how likely is it that opioid addiction will occur as a result if 
treating pain with opioid analgesics? Circle the number closest to what you consider 
the correct answer. 
<1-5% 25% 50% 75% 100% 
case studies 
Two patient case studies are presented For each patient you are asked to make 
decisions about pain and medication 
Directions: Please select one answer for each question 
36. Patient A : Andrew is 25 years old and this is his first day following abdominal 
surgery. As you enter his roo~ he smiles at you and continues talking and joking 
with his visitor. Your assessment reveals the following information: BP = 120/80; 
HR = 80; R = 18; on a scale of 0 to 10 (0 = no pain/discomfort, 10 = worst 
painldiscomfort) he rates his pain as 8. 
On the patient's record you must mark his pain on the scale below. Circle the number 
that represents your assessment of Andrew's pain. 
o 1 2 3 4 5 6 7 8 9 10 
No pain/discomfort Worst painldiscomfort 
Your assessment, above, is made two hours after he received morphine 2mg IV. Half 
hourly pain ratings following the injection ranged from 6 to 8 and he has no clinically 
significant respiratory depression, sedation, or other untoward side effects. He has 
identified 2 as an acceptable level of pain relief. His physician's order for analgesia is 
''morphine IV 1-3mg qlhr PRN pain relief'. Check the action you will take at this 
time 
a Administer no morphine at this time 
b. Administer morphine Img IV now 
c. Administer morphine 2mg IV now 
d. Administer morphine 3mg IV now 
37. Patient B : Robert is 25 years old and this is his first day following abdominal 
surgery. As you enter his room, he is lying quietly in bed and grimaces as he turns in 
bed. Your assessment reveals the following information: BP = 120/80; HR = 80; R 
= 18; on a scale of 0 to 10 (O=no pain/discomfort) he rates his pain as 8. 
On the patient's record you must mark his pain on the scale below. Circle the number 
that represents your assessment of Robert's pain 
o 1 2 3 4 5 6 7 8 9 10 
No pain/discomfort Worst pain/discomfort 
Your assessment, above, is made two hours after he received morphine 2mg IV. Half 
hourly pain ratings following the injection ranged from 6 to 8 and he has no clinically 
significant respiratory depression, sedation, or other untoward side effects. He has 
identified 2 as an acceptable level of pain relief. His physician's order for analgesia is 
"morphine IV 1-3mg qlhr PRN pain relief'. Check the action you will take at this 
time 
a Administer no morphine at this time 
b. Administer morphine Img IV now 
c. Administer morphine 2mg IV now 
d. Administer morphine 3mg IV now 
REFERENCES 
1 van Roenn J H, Cleeland C S, Gronin R, et at Physician attitudes and practice in 
cancer pain management. A survey from the Eastem Cooperative Oncology Group, 
Annals Int Med 119 (2), 121-126, 1993 
2 Abraham J. Management of pain and spinal cord compression in patients with 
advanced cancer. Ann Int Med 131(1) 37-46,1999 
3 Cleeland C J, Janjan N A, Scott C B, Seiferheld W F, Curran W J. Cancer pain 
management by radiotherapists: A survey of radiation therapy oncology group 
physicians. Int J Radiat Oncol Bioi Phys 47: 203-208,2000 
4 Lebovits A H, Florence I, Batilhina R, Hunko B V, Fox M T, Bramble C Y. Pain 
knowledge and attitudes of healthcare providers: practice characteristic differences. 
Clin J Pain 13: 237-243, 1997 
5 Beck S L, Falkson G. Prevalence and management of cancer pain in South Africa. 
Pain (94) 75-84, 2001 
6 Cleeland C J, Gronin R, Hatfield A K, Edmonson J H, Blum R H, Stewart J A, 
pandya K. Pain and its treatment in outpatients with metastatic cancer. The New 
Engl J Med 330: 592-596, 1995 
7 Doyle 0, Hanks G W C, MacDonald N. Oxford textbook of palliative medicine. ~ 
edition, Oxford University Press, 2001 
8 Grossman S A, Scheiller V R,. Cancer pain. In: de Vita V T, Hellman S, Rosenberg 
S A. Cancer: Principles and practice of oncology, 5th edition. Philadelphia. J 
Uppincott, 1996 
9 National Cancer Institute. PDQ - Pain Edition 512002 
10 Anon. Practice guidelines for cancer pain management. A report by the American 
Society of Anesthesiologists task force on pain management Anesthesiology 84: 
1243-1257, 1996 
11 Grossman J A, Benedetti C, Payne R, Syriala K NCCN Practice guidelines for 
cancer pain. Oncology 13(11A) Nov 1999 
12 Sommers de K. Sommers' Pharmacology. 1st English Edition. Up Drukkers, 
2000 
13 Woodruff R. Palliative Medicine, 3rd edition. Oxford University Press, 1999 
14 Jacox A, Carr 0, Payne R, Berde C, et al,. Management of cancer pain: Adults 
quick reference guide No 9 AHCPR publication No 94-0593. US Department of 
Health and Human Services, Public Health Service, March 1994 
15 Ferrell B R, McCaffery M. Nurse knowledge about equianalgesia and opioid 
dosing. Cancer Nursing 20(3) 201-212,1997 
16 Anon. Fortnightly review: Morphine in cancer pain. Modes of administration. Br 
Med J 312: 823-826,1996 
17 Dalton J A, Youngblood R. Clinical application of the Wor1d Health Organization 
analgesic ladder. J IV Nursing 23: 118-124,2000 
18 Wood J J. Pharmacological treatment of cancer pain. New Engl J Med 335: 1124-
1132, 1996 
19 Max M B, Payne R, Edwards W T, Sunshire A, Intumisi C E. Principles of 
analgesic use in the treatment of acute pain and cancer pain. Amer Pain Soc, Forth 
Ed, 1999 
20 McCaffey M, Ferrell B R, Nurses knowledge about cancer pain: A survey of five 
countries. J Pain Symptom Manage 10(5) 356-367,1995 
21 Ferrell G R, McGuire D B, Donovan M I. Knowledge and beliefs regarding pain in 
a sample of nursing faculty. J Prof Nursing 9 (2) 79-88, 1993 
22 Ferrell B R, Dean G E, Grant M, CoIuzzi P. An institutional commitment to pain 
management. J Clin OncoI13(9) 2158-2165,1995 
23 Janes J. On research: Survey construction. Library Hi Tech, 17: 321-325, 1999 
24 Worfd Medical Association Declaration of Helsinki. Ethical principles for medical 
research involving human subjects. 5200 WMA General Assembly, Edinburgh, 
ScoUand.~ober2ooo. 
25 Elliot T E, Murray D M, Elliot Bf Braun B, Oken M, Johnson K, Post-White J, 
Lichtblau L. Physician knowledge and attitudes about cancer pain management: A 
survey from the Minnesota cancer pain project. J Pain Symptom manage 10(7) 494-
505, October 1995. 
26 Furstenberg C T, Ahlers T A, Whedon M Bf Pierce K L, Dolan M, Roberts L, 
Silberfarb P M. Knowledge and attitudes of health-care providers toward cancer pain 
management: A comparison of physicians, nurses and phannacists in the state of 
New Hampshire. J Pain Symptom manage 15(6) 335-349, June 1998. 
27 Hollen C J, Hollen C W, Stolte K. Hospice and hospital oncology unit nurses: a 
comparative survey of knowledge and attitudes about cancer pain. Onco Nursing 
Forum 27(10):1593-9, Nov-Dec 2000. 
28 Levin M L, Berry J I , Leiter J. Management of pain in terminally ill patients: 
physicain reports of knowledge, attitudes and behaviour. J Pain Symptom manage 
15(1):27-40, Jan 1998. 
29 Larue F, Colleau S M, Fontaine A, Brasseur L. OncologiSts and primary care 
physicians' attitudes toward pain control and morphine prescribing in France. Cancer 
76(11):2375-82, Dec 1995. 
3{) Visentin M, Trentin L, de Marco R, Zanolin E. Knowledge and attitudes of Italian 
medical staff towards the approach and treatment of patients in pain. J Pain 
Symptom manage, 22(5):925-30, Nov 2001. (Abstract) 
31 Bauwens S, Oistelmans W, Stoeme G, Kaufman L. Attitudes and knowledge about 
cancer pain in Flanders. The educational effect of workshops regarding pain and 
symptom control. Palliative Medicine, 15(3):181-9, May 2001. (Abstract) 
32 Weistein S M, Laux L F, Thomby J L, Lorimor R J, Hill C , Thorpe 0 M,MerriI J M. 
Physician's attitudes toward pain and the use of opioid analgesics: results of a survey 
from the Texas Cancer Pain Initiative. Southern Medical Journal, 93(5):479-87, May 
2000. (Abstract) 
33 Weistein S M, Laux L F, Thomby J L, Lorimor R J, Hill C , Thorpe 0 M,Menil J M. 
Medical student's attitudes toward pain and the use of opioid analgesics: implications 
for changing medical school curriculum. Southern Medical Journal, 93(5):472-8, May 
2000. (Abstract) 
34 Heath 0 L. Nurses' knowledge and attitudes concerning pain management in an 
Australian hospital. Australian J of Advanced Nursing, 16(2):15-8, Dec1998- Feb 
1999. (Abstract) 
35 Larue F, Colleau S M, Fontaine A, Brasseur L. Oncologists and primary care 
physicians attitudes toward pain control and morphine presaibing in France. Cancer, 
76(11):2375-82, Dec 1995. 
38 Ger L, Ho S, Wang J. Physicians knowledge and attitudes toward the use of 
analgesics for cancer pain management: A survey of two medical centres in Taiwan. 
J Pain Symptom manage, 20(5):335-344, Nov 2000. 
37 Sapir R, Catane R, Strauss-Liviatan N, Cherny N I. Cancer Pain: Knowledge and 
attitudes of physicians in Israel. J Pain Symptom manage 17(4):266-276, April 1999. 
38 Clarke E B, French B, Bilodeau M L, Capasso V C, Edwards A, Empoliti J. Pain 
management knowledge, attitudes and clinical practice: the impact of nurse's 
characteristics and education. J Pain Symptom manage 11 (1): 18-31, Jan 1996. 
39 Beck S L. An ethnographic study of factors influencing cancer pain management in 
South Africa. Cancer Nursing 23(2):91-99, Apr 2000. 
40 Beck S L. Health policy, health services, and cancer pain management in the new 
South Africa. J Pain Symptom manage 17(1):16-26, Jan 1999. 
41 Dawson B, Trapp R G. Basic and clinical biostatistics. 3rd Edition.McGraw-Hili 
Companies, 2001. 
42 Sousa V 0, Zaauszniewski J A, Musil C M. How to determine whether a 
convenience sample represents the population. App Nurs Res 17(2):130-133, May 
2004. 
43 Delnevo C 0, Abatemarco 0 J, Steinberg M B. Physician response rates to a mail 
survey by specialty and timing of incentive. Am J Prev Med 26(3):234-236, 2004. 
